IRE-3 - IRE1a Modulator. CAS# 1414938-21-8 60116 CD-14-1029

CD-14-1029

AZD-2281 increases vascular perfusion in Calu-6 tumors established in a DWC model

with an IC50 of 14 nM

It significantly inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concentration of 0

AZD-2281 was approved in 2014 for treating advanced ovarian cancer

IRE-3 - IRE1a Modulator. CAS# 1414938-21-8 60116 CD-14-1029IRE 3, CAS No. 1414938 21 8, is a highly potent and selective small molecule modulator of IRE1. Under endoplasmic reticulum stress, unfolded protein accumulation leads to activation of the endoplasmic reticulum transmembrane kinase endoRNase (RNase) IRE1. IRE1 oligomerizes, autophosphorylates and initiates splicing of XBP1 mRNA, thus triggering the unfolded protein response (UPR). Interestingly, IRE 3 inhibits the XBP1 mRNA splicing through binding to